Logo image of B4B.DE

METRO AG (B4B.DE) Stock Fundamental Analysis

FRA:B4B - Deutsche Boerse Ag - DE000BFB0019 - Common Stock - Currency: EUR

5.39  0 (0%)

Fundamental Rating

2

Overall B4B gets a fundamental rating of 2 out of 10. We evaluated B4B against 26 industry peers in the Consumer Staples Distribution & Retail industry. B4B has a bad profitability rating. Also its financial health evaluation is rather negative. B4B has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year B4B has reported negative net income.
In the past year B4B had a positive cash flow from operations.
In multiple years B4B reported negative net income over the last 5 years.
B4B had a positive operating cash flow in each of the past 5 years.
B4B.DE Yearly Net Income VS EBIT VS OCF VS FCFB4B.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

The Return On Assets of B4B (-1.41%) is worse than 73.08% of its industry peers.
Looking at the Return On Equity, with a value of -9.95%, B4B is doing worse than 76.92% of the companies in the same industry.
B4B's Return On Invested Capital of 2.36% is on the low side compared to the rest of the industry. B4B is outperformed by 76.92% of its industry peers.
Industry RankSector Rank
ROA -1.41%
ROE -9.95%
ROIC 2.36%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
B4B.DE Yearly ROA, ROE, ROICB4B.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

B4B has a worse Operating Margin (0.58%) than 76.92% of its industry peers.
In the last couple of years the Operating Margin of B4B has declined.
B4B has a worse Gross Margin (16.26%) than 73.08% of its industry peers.
In the last couple of years the Gross Margin of B4B has remained more or less at the same level.
Industry RankSector Rank
OM 0.58%
PM (TTM) N/A
GM 16.26%
OM growth 3Y-26.08%
OM growth 5Y-24.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.57%
GM growth 5Y-0.91%
B4B.DE Yearly Profit, Operating, Gross MarginsB4B.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1

2. Health

2.1 Basic Checks

B4B has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for B4B remains at a similar level compared to 5 years ago.
B4B.DE Yearly Shares OutstandingB4B.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2024 100M 200M 300M
B4B.DE Yearly Total Debt VS Total AssetsB4B.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2024 5B 10B 15B

2.2 Solvency

B4B has an Altman-Z score of 2.20. This is not the best score and indicates that B4B is in the grey zone with still only limited risk for bankruptcy at the moment.
B4B has a Altman-Z score of 2.20. This is in the lower half of the industry: B4B underperforms 73.08% of its industry peers.
B4B has a debt to FCF ratio of 11.48. This is a negative value and a sign of low solvency as B4B would need 11.48 years to pay back of all of its debts.
B4B has a Debt to FCF ratio of 11.48. This is in the lower half of the industry: B4B underperforms 73.08% of its industry peers.
B4B has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
B4B has a worse Debt to Equity ratio (1.80) than 88.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 11.48
Altman-Z 2.2
ROIC/WACC0.47
WACC4.98%
B4B.DE Yearly LT Debt VS Equity VS FCFB4B.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

B4B has a Current Ratio of 0.77. This is a bad value and indicates that B4B is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.77, B4B is doing worse than 73.08% of the companies in the same industry.
A Quick Ratio of 0.41 indicates that B4B may have some problems paying its short term obligations.
B4B has a worse Quick ratio (0.41) than 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.41
B4B.DE Yearly Current Assets VS Current LiabilitesB4B.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2024 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

B4B shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -467.04%.
B4B shows a small growth in Revenue. In the last year, the Revenue has grown by 3.04%.
The Revenue has been growing slightly by 2.76% on average over the past years.
EPS 1Y (TTM)-467.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.67%
Revenue 1Y (TTM)3.04%
Revenue growth 3Y7.81%
Revenue growth 5Y2.76%
Sales Q2Q%5.63%

3.2 Future

Based on estimates for the next years, B4B will show a very strong growth in Earnings Per Share. The EPS will grow by 72.78% on average per year.
The Revenue is expected to grow by 3.03% on average over the next years.
EPS Next Y125.95%
EPS Next 2Y102.28%
EPS Next 3Y72.78%
EPS Next 5YN/A
Revenue Next Year3.37%
Revenue Next 2Y3.29%
Revenue Next 3Y3.28%
Revenue Next 5Y3.03%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
B4B.DE Yearly Revenue VS EstimatesB4B.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
B4B.DE Yearly EPS VS EstimatesB4B.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.5 -0.5 1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for B4B. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 17.57, which indicates a rather expensive current valuation of B4B.
61.54% of the companies in the same industry are cheaper than B4B, based on the Price/Forward Earnings ratio.
B4B's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.70.
Industry RankSector Rank
PE N/A
Fwd PE 17.57
B4B.DE Price Earnings VS Forward Price EarningsB4B.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

92.31% of the companies in the same industry are more expensive than B4B, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, B4B is valued cheaper than 84.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.92
EV/EBITDA 3.9
B4B.DE Per share dataB4B.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as B4B's earnings are expected to grow with 72.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y102.28%
EPS Next 3Y72.78%

0

5. Dividend

5.1 Amount

No dividends for B4B!.
Industry RankSector Rank
Dividend Yield N/A

METRO AG

FRA:B4B (2/21/2025, 7:00:00 PM)

5.39

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)02-05 2025-02-05
Earnings (Next)05-15 2025-05-15
Inst Owners6.72%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.96B
Analysts50.77
Price Target4.98 (-7.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-114.86%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.79%
PT rev (3m)-9.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-83.39%
EPS NY rev (3m)-83.39%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)0.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.57
P/S 0.06
P/FCF 4.92
P/OCF 2.51
P/B 1.11
P/tB 4.75
EV/EBITDA 3.9
EPS(TTM)-0.5
EYN/A
EPS(NY)0.31
Fwd EY5.69%
FCF(TTM)1.1
FCFY20.34%
OCF(TTM)2.15
OCFY39.8%
SpS86.71
BVpS4.84
TBVpS1.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.41%
ROE -9.95%
ROCE 3.27%
ROIC 2.36%
ROICexc 3.32%
ROICexgc 5.01%
OM 0.58%
PM (TTM) N/A
GM 16.26%
FCFM 1.26%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-12.72%
ROICexcg growth 5Y-10.79%
ROICexc growth 3Y-15.94%
ROICexc growth 5Y-14.09%
OM growth 3Y-26.08%
OM growth 5Y-24.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.57%
GM growth 5Y-0.91%
F-Score3
Asset Turnover2.53
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 11.48
Debt/EBITDA 2.89
Cap/Depr 41.87%
Cap/Sales 1.21%
Interest Coverage 2.33
Cash Conversion 71.21%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.41
Altman-Z 2.2
F-Score3
WACC4.98%
ROIC/WACC0.47
Cap/Depr(3y)36.78%
Cap/Depr(5y)30.8%
Cap/Sales(3y)1.13%
Cap/Sales(5y)0.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-467.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.67%
EPS Next Y125.95%
EPS Next 2Y102.28%
EPS Next 3Y72.78%
EPS Next 5YN/A
Revenue 1Y (TTM)3.04%
Revenue growth 3Y7.81%
Revenue growth 5Y2.76%
Sales Q2Q%5.63%
Revenue Next Year3.37%
Revenue Next 2Y3.29%
Revenue Next 3Y3.28%
Revenue Next 5Y3.03%
EBIT growth 1Y-48.31%
EBIT growth 3Y-20.31%
EBIT growth 5Y-22.66%
EBIT Next Year437.82%
EBIT Next 3Y77.01%
EBIT Next 5Y38.9%
FCF growth 1Y73.8%
FCF growth 3Y-12.68%
FCF growth 5Y-13.49%
OCF growth 1Y39.11%
OCF growth 3Y-4.45%
OCF growth 5Y-8.74%